78 related articles for article (PubMed ID: 17185761)
1. Detecting mutations that confer oxazolidinone resistance in gram-positive bacteria.
Woodford N; North SE; Ellington MJ
Methods Mol Biol; 2007; 373():103-14. PubMed ID: 17185761
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of Staphylococcus aureus and Enterococcus faecalis mutants with reduced susceptibility to the investigational oxazolidinone RWJ-416457.
Santoro CM; Bush K; Abbanat D
Int J Antimicrob Agents; 2010 Nov; 36(5):424-9. PubMed ID: 20846828
[TBL] [Abstract][Full Text] [Related]
3. Oxazolidinones: activity, mode of action, and mechanism of resistance.
Bozdogan B; Appelbaum PC
Int J Antimicrob Agents; 2004 Feb; 23(2):113-9. PubMed ID: 15013035
[TBL] [Abstract][Full Text] [Related]
4. Zyvox Annual Appraisal of Potency and Spectrum program: linezolid surveillance program results for 2008.
Jones RN; Ross JE; Bell JM; Utsuki U; Fumiaki I; Kobayashi I; Turnidge JD
Diagn Microbiol Infect Dis; 2009 Dec; 65(4):404-13. PubMed ID: 19913683
[TBL] [Abstract][Full Text] [Related]
5. Persistence of rRNA operon mutated copies and rapid re-emergence of linezolid resistance in Staphylococcus aureus.
Tsakris A; Pillai SK; Gold HS; Thauvin-Eliopoulos C; Venkataraman L; Wennersten C; Moellering RC; Eliopoulos GM
J Antimicrob Chemother; 2007 Sep; 60(3):649-51. PubMed ID: 17623697
[TBL] [Abstract][Full Text] [Related]
6. Reversion to susceptibility in a linezolid-resistant clinical isolate of Staphylococcus aureus.
Meka VG; Gold HS; Cooke A; Venkataraman L; Eliopoulos GM; Moellering RC; Jenkins SG
J Antimicrob Chemother; 2004 Oct; 54(4):818-20. PubMed ID: 15347637
[TBL] [Abstract][Full Text] [Related]
7. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA.
Meka VG; Pillai SK; Sakoulas G; Wennersten C; Venkataraman L; DeGirolami PC; Eliopoulos GM; Moellering RC; Gold HS
J Infect Dis; 2004 Jul; 190(2):311-7. PubMed ID: 15216466
[TBL] [Abstract][Full Text] [Related]
8. Activity of oxazolidinone TR-700 against linezolid-susceptible and -resistant staphylococci and enterococci.
Livermore DM; Mushtaq S; Warner M; Woodford N
J Antimicrob Chemother; 2009 Apr; 63(4):713-5. PubMed ID: 19164418
[TBL] [Abstract][Full Text] [Related]
9. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype.
Pillai SK; Sakoulas G; Wennersten C; Eliopoulos GM; Moellering RC; Ferraro MJ; Gold HS
J Infect Dis; 2002 Dec; 186(11):1603-7. PubMed ID: 12447736
[TBL] [Abstract][Full Text] [Related]
10. Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
Jones RN; Moet GJ; Sader HS; Fritsche TR
J Antimicrob Chemother; 2004 May; 53(5):804-7. PubMed ID: 15056649
[TBL] [Abstract][Full Text] [Related]
11. Nosocomial outbreak of linezolid-resistant Enterococcus faecalis infection in a tertiary care hospital.
Gómez-Gil R; Romero-Gómez MP; García-Arias A; Ubeda MG; Busselo MS; Cisterna R; Gutiérrez-Altés A; Mingorance J
Diagn Microbiol Infect Dis; 2009 Oct; 65(2):175-9. PubMed ID: 19717261
[TBL] [Abstract][Full Text] [Related]
12. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus.
Morales G; Picazo JJ; Baos E; Candel FJ; Arribi A; Peláez B; Andrade R; de la Torre MA; Fereres J; Sánchez-García M
Clin Infect Dis; 2010 Mar; 50(6):821-5. PubMed ID: 20144045
[TBL] [Abstract][Full Text] [Related]
13. Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
Anderegg TR; Sader HS; Fritsche TR; Ross JE; Jones RN
Int J Antimicrob Agents; 2005 Jul; 26(1):13-21. PubMed ID: 15967640
[TBL] [Abstract][Full Text] [Related]
14. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit.
Johnson AP; Tysall L; Stockdale MV; Woodford N; Kaufmann ME; Warner M; Livermore DM; Asboth F; Allerberger FJ
Eur J Clin Microbiol Infect Dis; 2002 Oct; 21(10):751-4. PubMed ID: 12415476
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance to linezolid.
Meka VG; Gold HS
Clin Infect Dis; 2004 Oct; 39(7):1010-5. PubMed ID: 15472854
[TBL] [Abstract][Full Text] [Related]
16. Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo.
Bourgeois-Nicolaos N; Massias L; Couson B; Butel MJ; Andremont A; Doucet-Populaire F
J Infect Dis; 2007 May; 195(10):1480-8. PubMed ID: 17436228
[TBL] [Abstract][Full Text] [Related]
17. Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center.
Kloss P; Xiong L; Shinabarger DL; Mankin AS
J Mol Biol; 1999 Nov; 294(1):93-101. PubMed ID: 10556031
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in Enterococci.
Sinclair A; Arnold C; Woodford N
Antimicrob Agents Chemother; 2003 Nov; 47(11):3620-2. PubMed ID: 14576130
[TBL] [Abstract][Full Text] [Related]
19. ZAAPS International Surveillance Program (2007) for linezolid resistance: results from 5591 Gram-positive clinical isolates in 23 countries.
Jones RN; Kohno S; Ono Y; Ross JE; Yanagihara K
Diagn Microbiol Infect Dis; 2009 Jun; 64(2):191-201. PubMed ID: 19500528
[TBL] [Abstract][Full Text] [Related]
20. Decreased linezolid uptake in an in vitro-selected linezolid-resistant Staphylococcus epidermidis mutant.
Sierra JM; Ortega M; Tarragó C; Albet C; Vila J; Terencio J; Guglietta A
J Antimicrob Chemother; 2009 Nov; 64(5):990-2. PubMed ID: 19717395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
